Drug Channels Institute (DCI) is a leading source of industry research about pharmaceutical economics and the drug distribution system. >

Industry Reports

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >

The 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

Copay + GTN Revenue Protection = Better Together

Today's guest post comes from Gerard Rivera, Co-Founder & CEO at RIS Rx. Gerard Rivera examines how copay programs and real-time gross-to-net (GTN) revenue protection can work together to more >

Alternative PBM Satisfaction Declined in 2026, Shrinking the Advantage Over the Big Three PBMs

By Bryce Platt, PharmD PBMs outside the Big Three still earn higher customer satisfaction ratings, but their lead has nearly disappeared. Meanwhile, more >